Two studies link elevated ear protein levels in blood to tinnitus
· Medical Xpressby Loretta Waldman, University of Connecticut
edited by Sadie Harley, reviewed by Robert Egan
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Senior Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
trusted source
proofread
The GIST Add as preferred source
When Dr. Kourosh Parham conceived a first-of-its-kind blood test for tinnitus, he knew further research was needed to confirm a link between a unique ear protein and the common hearing disorder. To validate his theory, the professor of surgery at UConn Health (UCH), Division of Otolaryngology-Head & Neck Surgery, teamed up with fellow UCH physician-scientists to conduct two clinical trials.
Five years later, the findings of their studies, published in the journals Otology & Neurotology and Otolaryngology–Head & Neck Surgery, respectively, offer the strongest evidence yet that the protein, called prestin, may play a role in tinnitus. Parham hopes the breakthrough will spark larger studies and the development of a drug to treat the condition.
Prestin links ear cells and tinnitus
In both studies, Parham and fellow researchers Dr. Daniel Roberts, a neurotologist in the Department of Surgery's Division of Otolaryngology–Head & Neck Surgery, and Dr. Erika Skoe, a hearing scientist in the Department of Speech, Language and Hearing Sciences, found elevated levels of prestin in individuals with tinnitus.
Prestin enables outer hair cell (OHC) function in the cochlea, the snail-shaped organ in the inner ear. OHCs are specialized cells that amplify sound vibrations in the inner ear and fine-tune hearing sensitivity.
"We now have proof of concept that an ear protein may play a central role in the development and management of tinnitus," says Parham. "Our work now says there is promise in using prestin as a biomarker for tinnitus. This is our first step to developing drugs to help manage tinnitus."
While hearing loss can be inherited, it is most often acquired through acoustic trauma, prolonged exposure to loud noise or toxicity from medications such as chemotherapy, which can damage the intricate cellular components of the inner ear.
Tinnitus is a common condition associated with hearing loss. It is characterized by a persistent, unexplained ringing, buzzing or banging in one or both ears, heard only by the person experiencing it. It affects approximately 11% of Americans and 15% of the global population. At its worst, the condition can have a significant impact on quality of life, from sleep disturbances and cognitive dysfunction to anxiety and depression.
A blood measure for subjective symptoms
When Parham began researching inner ear problems about 40 years ago, tinnitus was an enigma. It was while exploring biomarkers for vertigo, and later prestin as a biomarker for noise-induced hearing loss and certain cancer drugs, that he became aware of an experimental study of aspirin toxicity, commonly associated with tinnitus, that pointed to prestin being a factor in the hearing disorder. Prestin sits inside the wall of the outer hair cell, which becomes longer or shorter based on the intensity of sound.
Parham speculated that some of the prestin spills into circulation under certain conditions, reflecting what is happening at the outer hair cell level. His now-patented blood test not only detects inner ear damage at an earlier stage but also helps inform clinicians about the extent of hearing loss by measuring the level of prestin in the blood.
When it comes to tinnitus, prestin may be the first objective assessment of what had previously been a subjective problem, Parham says. Before the test, doctors had to rely on reports from patients about the severity of their tinnitus based on assessments of how well they slept or how much stress they were feeling because of the tinnitus.
"Now, measuring prestin gives us a clinical indication of how bad the tinnitus is," he says.
Last year, Parham's research on prestin was highlighted in Tinnitus Today, a publication of the American Tinnitus Association.
Larger studies needed to confirm findings
The findings of the two recent studies are based on a small number of participants. The one published in March measured levels of prestin in 89 subjects: 49 with chronic tinnitus and 40 control subjects. The study published in July looked at levels of prestin and other proteins in 82 participants: 41 who reported chronic noise in both ears and 41 control subjects.
While it's tempting to jump to conclusions, Parham is urging caution at this stage. The results need to be replicated and confirmed in a larger sample of subjects. But replication and extension of the findings could firmly position serum prestin as a biological indicator for tinnitus.
"Having a biomarker for tinnitus is potentially a game changer," the March study notes. "Availability of a biomarker for tinnitus would offer a novel tool in future investigations that may position investigators to successfully gain insights into the mechanisms that contribute to the generation of tinnitus and identify specific targets for interventions."
More information
Patrick Adamczyk et al, Elevation of Serum Prestin in Patients With Tinnitus: Pathophysiological Implications and Biomarker Potential, Otology & Neurotology (2025). DOI: 10.1097/mao.0000000000004789
Patrick Adamczyk et al, Serum Levels of Prestin, Otoferlin, Connexin 26, and Stereocilin: A Biomarker Approach to Tinnitus, Otolaryngology–Head and Neck Surgery (2026). DOI: 10.1002/ohn.70382
Key medical concepts
Clinical categories
NeurologyCommon illnesses & Prevention Provided by University of Connecticut Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Two studies link elevated ear protein levels in blood to tinnitus (2026, October 6) retrieved 6 October 2026 from https://medicalxpress.com/news/2026-10-link-elevated-ear-protein-blood.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.